Skip to main content
. Author manuscript; available in PMC: 2022 Aug 9.
Published in final edited form as: JAMA. 2021 Sep 7;326(9):851–862. doi: 10.1001/jama.2021.13027

Figure 2.

Figure 2.

Novel Targets and Agents in Development in Pancreatic Cancer

ADB indicates adenosine diphosphate; CA, carbohydrate antigen;

CEA, carcinoembryonic antigen; CSF, colony-stimulating factor; DDR, DNA damage repair, EGFR, epidermal growth factor receptor; ILC, innate lymphoid cell; and TH1, type 1 helper T cell.

a Approved by the US Food and Drug Administration or guideline-endorsed for pancreatic cancer.